New protease inhibitor available through expanded access.
D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006297:Health Services Accessibility; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors